Prophylaxis: Who, what, when, and why?

Joel E. Gallant, Henry Masur, William G. Powderly

Research output: Contribution to journalArticle

Abstract

Chemoprophylaxis for more than a dozen opportunistic infections now allows people with HIV disease to live longer and better lives. Devising an effective regimen is a tough job, but one you can expect to be doing.

Original languageEnglish (US)
Pages (from-to)77-97
Number of pages21
JournalPatient Care
Volume30
Issue number9
StatePublished - May 15 1996

ASJC Scopus subject areas

  • Leadership and Management

Fingerprint Dive into the research topics of 'Prophylaxis: Who, what, when, and why?'. Together they form a unique fingerprint.

  • Cite this

    Gallant, J. E., Masur, H., & Powderly, W. G. (1996). Prophylaxis: Who, what, when, and why? Patient Care, 30(9), 77-97.